semaglutide to mounjaro conversion Can you switch from Wegovy Mounjaro? GLP-1RA and Dual GLP-1RA/GIP:

To stay with the times, the Federal Aviation Administration has quietly modernized its approach to weight-loss treatment []

This affordability equation is expected to shift significantly after the patent on Semaglutide expires in China and India in 2026

Their lead candidate, ECC5004, is an oral GLP-1 agonist licensed to AstraZeneca for global development (excluding China), while Eccogene retains co-development and co-commercialization rights in China

Ozempic, Wegovy and Mounjaro accounted for nearly $4-billion in sales at retail pharmacies in 2025, according to IQVIA Canada

This fella health review focuses on their GLP-1 medications and we interview 3 men who used Semaglutide for weight loss